INTRODUCTION
Myoid cells (MCs) constitute a normal component of the thymic connective tissue stroma. These cells are situated mainly in the medulla and at the corticomedullar junction. They are large, rounded cells, with a central nucleus surrounded by irregularly arranged bundles of myofilaments. In lower vertebrates, where myoid cells are often more numerous, these cells are joined to neighbouring medullary epithelial cells by desmosomes. Their functions are unknown, although it has been suggested that their contractions might aid the movement of lymphoid cells across or out of the gland.
Myoid cells share some characteristics with thymic epithelial cells (1) , and it has been suggested that myoid cells may derive from myoepithelial cells within the thymus (2) . Other reports have suggested that myoid cells come from pluripotent stem cells(3), or from endodermal reticular cells. It has also been postulated that they are of extrathymic origin, arising during embryogenesis from muscle precursor cells of the surrounding mesoderm (1) . Experiments with chick/quail chimeras do not support the notion that myoid cells arise from transdifferentiation of thymic epithelial cells but are rather of neuroectodermal origin (4) . Thymic myoid cells express several muscle-specific proteins including troponin T, desmin (5) , and the acetylcholine receptor (AChR)(5) (6). They have therefore the antigenic characteristics of the skeletal muscle cells within the thymus (7) . Their biological role is unclear, but their involvement in human myasthenia gravis (MG) has been suggested(3). Van de velde and Friedman reported that myoid cells were present in thymus and in thymoma from both young and adult patients with MG (8) .
MATERIALS AND METHODS

Materials:
Fifteen cases of thymic foetal specimens in different stages of development obtained after pregnancy failure due to chorioamnionitis (five samples), to implantation of the foetus in the region of the internal os resulting in placenta praevia (six samples), and to endometriosisadenomyosis (four samples).
Selection Criteria: All cases were chosen from specific time of development (4 th to 8 th weeks: five cases, 16 th to 20 th weeks: five cases and 28 th to 32 nd weeks: five cases respectively). The study was executed in harmony with the guidelines for the analysis of foetal cells, tissues and approved by the Ethics Committee of the General Hospital of Alexandroupolis.
Study Design: Tissue samples were processed for paraffin section immunophenotyping and stained using the monoclonal antibodies against alpha-smooth muscle actin (alpha-SMA) and glycophorin C by DAKO.
Methods: The sections were examined independently by two observers and positive cellular staining for alpha-smooth muscle actin and glycophorin C antibodies were manifested as fine yellow cytoplasmic granularity and/or surface membrane expression. They were examined with a X 40 objective and the distribution of the above antigens within the cell was recorded. Every stained cell was scored as positive regardless of staining intensity. To count the number of cells with alpha-smooth muscle actin and glycophorin C stainings, a 10 by 10 square calibrated grid was inserted into the eyepiece of an Olympus BX40 binocular microscope. Five-to-ten fields were examined for each section, and at least 1000 cells were scored, depending on cellularity. The indices ranged from 0-100%, with a mean of 18%. The mean index was evaluated in three ranges: low index (under 18%), grade I; moderate index (from 18 to 50%), grade II; and high index (from 51 to 100%), grade III. The statistical analysis was obtained using the t-test. The mean values were expressed as average +SD. Our results demonstrated a statistically significant difference in the 16 th to 20 th weeks of gestation concerning the expression of alpha-smooth muscle actin in the connective tissue stroma of the thymic medulla over the equivalent expression of the protein in the 4 th to 8 th weeks (p<0.0001, t-test) and 28 th to 32 nd weeks (p<0.0001, t-test). Similar changes in the above period were found concerning the expression of glycophorin C over the 4 th to 8 th weeks (p<0.0001, t-test) and 28 th to 32 nd weeks (p<0.0001), suggesting a direct involvement of alpha-smooth muscle actin in the backing up of erythropoietic activity. Out of seven fetuse-cases with positive alphasmooth muscle actin expression during the 4 th to 8 th weeks, five were scored as grade I, and II as grade III. Out of 15 fetuse-cases with positive, alpha smooth muscle actin expression during the 16 th to 20 th weeks, four were scored as grade one, nine as grade II, and two as grade III (Figure 1) . Out of eight fetuse-cases with positive alpha-smooth muscle actin expression during the 28 th to 32 nd weeks, four were scored as grade one, two as grade II, and two as grade III.
RESULTS
Medullary
Out of ten fetuse-cases with positive glycophorin C expression during the 4 th to 8 th weeks, five were scored as grade one, three as grade II and two as grade III. Out of 15 fetuse-cases with positive. Glycophorin C expression during the 16 th to 20 th weeks, three were scored as grade I, seven as grade II, and five as grade III (Figure 2 ). Out of 13 fetuse-cases with positive glycophorin C expression during the 28 th to 32 nd weeks, two were scored as grade I, eight as grade II, and three as grade III. The role of myoid cells has been explored by coculturing the myoid cells with thymocytes. Interestingly, the myoid cell line appears to protect thymic cells from spontaneous apoptosis, while the human thymic epithelial cell line has no effect. The mechanism of the protective effect needs further investigation. It could be mediated by soluble factors or by direct cell contacts. The presence of the adhesion molecule LFA-3 (CD58) on myoid immortalised thymic cells (MITC)(10) makes possible interactions between myoid cells and most thymocytes that constitutively express CD2. Indeed LFA-3 is important in the interaction with thymocytes at both immature and mature stages of development (11) .
Human thymic myoid cells can be immortalised from thymic explant cultures. These cells express both the foetal and adult forms of muscle acetylcholine receptor (AChR) at the mRNA level. A Subunit AChR protein expression is detectable in MITC line by flow cytometry. MITC line express a functional AChR, as shown by patch-clamp analysis. AChR expression on MITC line is down-modulated by myasthenia gravis (MG) sera (15) , as on TE671 rhabdomyosarcoma cells, making MITC line an interesting tool for AChR antigenic modulation experiments. MITC line produces high levels of TNF-a and IL-8 and protects thymocytes from apoptosis, indicating that thymic myoid cells could play a role in thymocyte differentiation (10) .
The following experimental arguments support the myoid nature of MITC line: (i). In the postnatal thymus, thymic myoid cells express several striated-muscle-specific proteins, including myosin(12), desmin and troponin T (5). Accordingly, Wakkach et al. (10) found that MITC line was troponin T-positive and desmin-positive, but keratin-negative. In addition, the MITC line has similar phenotype characteristics as myoid cells ex vivo, according to AChR, MHC class I and class ll, LFA-3, and ICAM-1 antigens.
(ii). Wakkach's et al. (10) data clearly indicate the presence of MyoD transcripts in MITC cells. MyoD is expressed only in skeletal muscle, and activates myogenesis by directly binding to the control regions of muscle-specific genes (13) . Pluripotential stem cells in the thymus might express such a gene and develop into immature skeletal muscle cells in certain conditions. This is supported by the fact that cell types as different as osteocytes and chondrocytes can differentiate from thymus cells in appropriate conditions in vitro (14) . (iii). Human MITC line expressed AChR in both adult and foetal forms (10) . In addition, anti-AChR auto antibodies induced a loss of AChR on MITC cells in vitro, similarly to TE671 cells; this mechanism was also observed using the anti-MlR monoclonal antibody MAb 35. These results indicate that AChR present on these cells is recognised by antibodies found in MG sera.
Some of MG patients' antibodies may show a marked preference for adult or foetal AChR, and some patients (up to 7%) are negative in diagnostic assays using only foetal AChR. That could explain why 10 to 15% of patients with clinical MG have very low titers of antibodies (0.2 to 2 nmol/L) (15) . To enhance the sensitivity of the diagnostic assay for low-titer sera, Beeson et al. (16) used TE671 cells transfected with the epsilon subunit of AChR as a source of AChR antigen. Thus a mix of AChR extracts from TE671-e and TE671 cells, in which adult and foetal AChR are present, was as sensitive as AChR from amputated leg muscle in MG diagnostic assay. Wakkach's et al. (10) data show that MITC line expresses constitutively the adult and the foetal forms of the AChR, thus MITC line might be an appropriate source of AChR for titrating anti-AChR antibodies in MG sera, as well as for studies of their functional effects. Expression of major histocompatibility complex (MHC) molecules by components of the thymic microenvironments required for normal T cell development (17) and has been implicated in the selection of the emerging T cell repertoire.
In our series: (i) The comparative study of the quantitative percentage of alpha-smooth muscle actin expression at. 1 st , 2 nd and 3 rd trimester of gestation showed a statistically significant difference in the number of stromal myoid cells in the thymic medulla during the second trimester over the first (p<0.0001, t-test) and third trimesters (p<0.0001, t-test).
(ii) The comparative study of the quantitative percentage of glycophorin C for the identification of erythropoietic cells, at 1 st , 2 nd and 3 rd trimester of gestation showed a statistically significant difference in the number of the relevant cells of the thymic parenchyme during the second trimester over the first (p 0.0001 , ttest) and third trimesters (p<0.0001, t-test).
Taken together, our data indicate that stromal cells expressing alpha-smooth muscle actin upregulate thymic haematopoiesis, providing a suitable background for the proliferation and differentiation of erythropoietic cells in the fetal thymus. Our conclusion may be not a safe one due to the limited number of cases examined, but it is certainly intriguing for further investigation.
